 Co-Diagnostics NASDAQ:CODX Inc has announced that its Logix Smart SARS-CoV-2 2-Gene multiplex test is now available for sale in the UK after being validated according to the United Kingdom Health Security Agencys UKHSA Medical Devices Regulations 2021 under Coronavirus Test Device Approvals CTDA. The company said the Logix Smart test is available for sale through Client Life Science, Co-Diagnostics NASDAQ:CODX authorized distributor in the UK. 